发明名称 PREVENTION OF BONE ABSORPTION
摘要 <p>PURPOSE: To provide the medicine which contains a xanthineoxidase inhibitory substance and is useful for the diseases occurring in the excess bone resorption including osteoporosis. CONSTITUTION: The compd. of formula (X is S, O, methyl subtd. N; R is H, amino, 1 to 3C alkylamino, hydroxy; R<1> is hydroxy, OM; M is nontoxic cation; R<2> , R<3> are H, halogen, 1 to 3C alkyl, trifluoromethyl, 1 to 3C alkoxyl); for example, 3-(3-triflumethylphenyl)-4-aminoisothiazole-5-carboxylic acid are incorporated as essential components into this medicine. The medicine is useful for the prevention and treatment of the excessive bone resorption related with rheumatoid arthritis, osteoporosis, loosening of artificial orthesis, periodontal diseases, tumors or Paget's diseases. The excessive bone resorption may be reversed and the bones are accumulated again and are eventually approached to the bones of the original intensity. The dose is 0.1 to 100 mg/kg/day.</p>
申请公布号 JPH06329555(A) 申请公布日期 1994.11.29
申请号 JP19930223144 申请日期 1993.09.08
申请人 ELI LILLY & CO;RONDON HOSUPITARU MEDICAL KARETSUJI;SENTO JIYOOJISU HOSUPITARU MEDICAL SUKUULE 发明人 DEIBITSUDO RATSUSERU BUREIKU;JIRU AN PANETSUTA;MONE ZAIDEI
分类号 A61K31/415;A61K31/425;A61K45/00;A61P1/02;A61P19/10;A61P29/00;A61P43/00;C07D231/18;C07D231/38;C07D275/02;(IPC1-7):A61K45/00;C07D275/03 主分类号 A61K31/415
代理机构 代理人
主权项
地址